相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Primary biliary cholangitis: treatment
Nora Cazzagon et al.
CURRENT OPINION IN GASTROENTEROLOGY (2021)
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA
Jorn M. Schattenberg et al.
JOURNAL OF HEPATOLOGY (2021)
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
Anna Reig et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Aliya F. Gulamhusein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Current and potential treatments for primary biliary cholangitis
Raj A. Shah et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Primary biliary cholangitis management: controversies, perspectives and daily practice implications from an expert panel
Domenico Alvaro et al.
LIVER INTERNATIONAL (2020)
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Keith D. Lindor et al.
HEPATOLOGY (2019)
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis
Akira Honda et al.
HEPATOLOGY (2019)
The challenges of primary biliary cholangitis: What is new and what needs to be done
Terziroli Beretta-Piccoli Benedetta et al.
JOURNAL OF AUTOIMMUNITY (2019)
Diagnosis and Management of Primary Biliary Cholangitis
Zobair M. Younossi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
C. Corpechot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2017)
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
David Jones et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Predicting Risk in Primary Biliary Cholangitis
Bertus Eksteen
HEPATOLOGY (2016)
Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study
Willem J. Lammers et al.
GASTROENTEROLOGY (2014)
Early Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis of Primary Biliary Cirrhosis: Results of a 14-Year Cohort Study
Li-Na Zhang et al.
HEPATOLOGY (2013)
Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis
Njideka Momah et al.
LIVER INTERNATIONAL (2012)
Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
Christophe Corpechot et al.
JOURNAL OF HEPATOLOGY (2011)
Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis
Teru Kumagi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
Edith M. M. Kuiper et al.
GASTROENTEROLOGY (2009)
Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis
Nobuaki Azemoto et al.
JOURNAL OF GASTROENTEROLOGY (2009)
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2009)
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
Christophe Corpechot et al.
HEPATOLOGY (2008)
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
A Parés et al.
GASTROENTEROLOGY (2006)
分享论文
